Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
International Journal of Antimicrobial Agents
|
March 6, 2023
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020
James A Karlowsky, Sibylle H Lob, Fakhar Siddiqui, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2016
Complete Sequencing of Plasmids Containing blaOXA-163 and blaOXA-48 in Escherichia coli Sequence Type 131
Nicole Stoesser, Anna E Sheppard, Gisele Peirano, et al.
Journal of Medical Microbiology
|
February 10, 2023
<i>In vitro</i> activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-<i>Morganellaceae Enterobacterales</i> and <i>Pseudomonas aeruginosa</i> collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020
James A Karlowsky, Sibylle H Lob, Fakhar Siddiqui, et al.
Antimicrobial Agents and Chemotherapy
|
May 2, 2022
<i>In Vitro</i> Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020
James A Karlowsky, Sibylle H Lob, C Andrew DeRyke, et al.
Antimicrobial Agents and Chemotherapy
|
June 2, 2016
First Report of blaIMP-14 on a Plasmid Harboring Multiple Drug Resistance Genes in Escherichia coli Sequence Type 131
Nicole Stoesser, Anna E Sheppard, Gisele Peirano, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 22, 2024
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021
James A Karlowsky, Sibylle H Lob, Stephen P Hawser, et al.
Jac-Antimicrobial Resistance
|
August 14, 2023
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and <i>Pseudomonas aeruginosa</i> collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21
James A Karlowsky, Sibylle H Lob, Stephen P Hawser, et al.
Diagnostic Microbiology and Infectious Disease
|
May 19, 2007
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy
Mark J DiNubile, Ian R Friedland, Christina Y Chan, et al.
Journal of Global Antimicrobial Resistance
|
July 7, 2023
Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021
James A Karlowsky, Mark G Wise, Tai-Chin Hsieh, et al.
Emerging Infectious Diseases
|
October 22, 2016
Global Escherichia coli Sequence Type 131 Clade with bla<sub>CTX-M-27</sub> Gene
Yasufumi Matsumura, Johann D D Pitout, Ryota Gomi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
International Journal of Antimicrobial Agents
|
March 6, 2023
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020
James A Karlowsky, Sibylle H Lob, Fakhar Siddiqui, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2016
Complete Sequencing of Plasmids Containing blaOXA-163 and blaOXA-48 in Escherichia coli Sequence Type 131
Nicole Stoesser, Anna E Sheppard, Gisele Peirano, et al.
Journal of Medical Microbiology
|
February 10, 2023
<i>In vitro</i> activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-<i>Morganellaceae Enterobacterales</i> and <i>Pseudomonas aeruginosa</i> collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020
James A Karlowsky, Sibylle H Lob, Fakhar Siddiqui, et al.
Antimicrobial Agents and Chemotherapy
|
May 2, 2022
<i>In Vitro</i> Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020
James A Karlowsky, Sibylle H Lob, C Andrew DeRyke, et al.
Antimicrobial Agents and Chemotherapy
|
June 2, 2016
First Report of blaIMP-14 on a Plasmid Harboring Multiple Drug Resistance Genes in Escherichia coli Sequence Type 131
Nicole Stoesser, Anna E Sheppard, Gisele Peirano, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 22, 2024
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021
James A Karlowsky, Sibylle H Lob, Stephen P Hawser, et al.
Jac-Antimicrobial Resistance
|
August 14, 2023
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and <i>Pseudomonas aeruginosa</i> collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21
James A Karlowsky, Sibylle H Lob, Stephen P Hawser, et al.
Diagnostic Microbiology and Infectious Disease
|
May 19, 2007
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy
Mark J DiNubile, Ian R Friedland, Christina Y Chan, et al.
Journal of Global Antimicrobial Resistance
|
July 7, 2023
Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021
James A Karlowsky, Mark G Wise, Tai-Chin Hsieh, et al.
Emerging Infectious Diseases
|
October 22, 2016
Global Escherichia coli Sequence Type 131 Clade with bla<sub>CTX-M-27</sub> Gene
Yasufumi Matsumura, Johann D D Pitout, Ryota Gomi, et al.
Page
of 8